Organix (United States)

Recent papers from Organix (United States)

1. Potato ( Solanum tuberosum L.) Response to Amino Acids Biostimulants Treatment under Organic Farming SystemActa horticulturae et regiotecturae · 2026
2. Effect of Nitrification Inhibitors on the Soil Microbiome During Strawberry CultivationNitrogen · 2026
3. Synthesis and Discovery of Arylpiperidinylquinazolines: New Inhibitors of the Vesicular Monoamine TransporterJournal of Medicinal Chemistry · 2018
4. Matrix Metalloproteinase Inhibition by Heterotrimeric Triple‐Helical Peptide Transition State AnaloguesChemBioChem · 2015
5. Combined inhibition of monoacylglycerol lipase and cyclooxygenases synergistically reduces neuropathic pain in miceBritish Journal of Pharmacology · 2014
6. Targeting multiple cannabinoid anti‐tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancerBritish Journal of Pharmacology · 2014
7. The influence of beta-arrestin2 on cannabinoid CB1receptor coupling to G-proteins and subcellular localization and relative levels of beta-arrestin1 and 2 in mouse brainJournal of Receptors and Signal Transduction · 2013
8. Asexual Populations of the Human Malaria Parasite, Plasmodium falciparum, Use a Two-Step Genomic Strategy to Acquire Accurate, Beneficial DNA AmplificationsPLoS Pathogens · 2013
9. Novel 3‐substituted rimonabant analogues lack Δ9‐tetrahydrocannabinol‐like abuse‐related behavioural effects in miceBritish Journal of Pharmacology · 2013
10. A novel fluorophosphonate inhibitor of the biosynthesis of the endocannabinoid 2‐arachidonoylglycerol with potential anti‐obesity effectsBritish Journal of Pharmacology · 2012
11. Activation of Cannabinoid Receptor 2 Attenuates Leukocyte–Endothelial Cell Interactions and Blood–Brain Barrier Dysfunction under Inflammatory ConditionsJournal of Neuroscience · 2012
12. Δ8‐Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptorsBritish Journal of Pharmacology · 2011
13. Sensitivity to Δ9-tetrahydrocannabinol is selectively enhanced in beta-arrestin2−/− miceBehavioural Pharmacology · 2008
14. Cannabinoid CB 2 Receptor Activation Decreases Cerebral Infarction in a Mouse Focal Ischemia/Reperfusion ModelJournal of Cerebral Blood Flow & Metabolism · 2007
15. Cannabidiol displays unexpectedly high potency as an antagonist of CB₁and CB₂receptor agonistsin vitroBritish Journal of Pharmacology · 2007
16. The psychoactive plant cannabinoid, Δ 9 ‐tetrahydrocannabinol, is antagonized by Δ 8 ‐ and Δ 9 ‐tetrahydrocannabivarin in mice in vivoBritish Journal of Pharmacology · 2007
17. A biosynthetic pathway for anandamideProceedings of the National Academy of Sciences · 2006
18. 1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) Analogues:  A Promising Class of Monoamine Uptake InhibitorsJournal of Medicinal Chemistry · 2006
19. Inhibition of Cytosolic Phospholipase A₂α: Hit to Lead OptimizationJournal of Medicinal Chemistry · 2005
20. New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosisBritish Journal of Pharmacology · 2005